Ministry of Public Health, Democratic Republic of the Congo
19
1
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
10.5%
2 terminated/withdrawn out of 19 trials
86.7%
+0.2% vs industry average
37%
7 trials in Phase 3/4
0%
0 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo
Role: collaborator
Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo
Role: lead
Mpox Biology, Outcome, Transmission and Epidemiology
Role: collaborator
Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo
Role: collaborator
Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence
Role: collaborator
Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance
Role: collaborator
Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)
Role: collaborator
Screen and Treat Implementation for HAT Control
Role: collaborator
Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum Malaria
Role: collaborator
Cassava Intervention Project
Role: lead
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
Role: collaborator
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
Role: lead
RVF and Other Emerging Infectious Diseases in East and Central Africa
Role: collaborator
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cure
Role: collaborator
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection
Role: collaborator
Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo
Role: lead
Effectiveness of Well-child Clinics as the "Community" Basis of Step 10 of the Baby Friendly Hospital Initiative
Role: collaborator
Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
Role: collaborator
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Role: collaborator
All 19 trials loaded